In an age in which immunosuppression is the standard of care for many pediatric rheumatic diseases, balancing the risks and benefits of vaccinations is forefront. Three main issues—addressed in new guidelines—surround vaccination practices in these patients: safety, immunogenicity and effects of the vaccine on the underlying rheumatic disease.
- Ginger Janow
- Norman T. Ilowite
